In our in vitro experiment, we observed FOXA1 expression exclusively in the three hormone-receptor-positive breast cancer (HR+ BC) cell lines, with no detection in the triple-negative breast cancer (TNBC) cell lines. Here, NR4A1 is linked to triple-negative breast carcinoma.